-
1
-
-
0141885294
-
From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I
-
DOI 10.1161/01.CIR.0000087480.94275.97
-
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-1672. (Pubitemid 37243650)
-
(2003)
Circulation
, vol.108
, Issue.14
, pp. 1664-1672
-
-
Naghavi, M.1
Libby, P.2
Falk, E.3
Casscells, S.W.4
Litovsky, S.5
Rumberger, J.6
Badimon, J.J.7
Stefanadis, C.8
Moreno, P.9
Pasterkamp, G.10
Fayad, Z.11
Stone, P.H.12
Waxman, S.13
Raggi, P.14
Madjid, M.15
Zarrabi, A.16
Burke, A.17
Yuan, C.18
Fitzgerald, P.J.19
Siscovick, D.S.20
De, K.C.L.21
Aikawa, M.22
Airaksinen, K.E.J.23
Assmann, G.24
Becker, C.R.25
Chesebro, J.H.26
Farb, A.27
Galis, Z.S.28
Jackson, C.29
Jang, I.-K.30
Koenig, W.31
Lodder, R.A.32
March, K.33
Demirovic, J.34
Navab, M.35
Priori, S.G.36
Rekhter, M.D.37
Bahr, R.38
Grundy, S.M.39
Mehran, R.40
Colombo, A.41
Boerwinkle, E.42
Ballantyne, C.43
Insull Jr., W.44
Schwartz, R.S.45
Vogel, R.46
Serruys, P.W.47
Hansson, G.K.48
Faxon, D.P.49
Kaul, S.50
Drexler, H.51
Greenland, P.52
Muller, J.E.53
Virmani, R.54
Ridker, P.M.55
Zipes, D.P.56
Shah, P.K.57
Willerson, J.T.58
more..
-
2
-
-
0142053972
-
From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II
-
DOI 10.1161/01.CIR.0000087481.55887.C9
-
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772-1778. (Pubitemid 37296082)
-
(2003)
Circulation
, vol.108
, Issue.15
, pp. 1772-1778
-
-
Naghavi, M.1
Libby, P.2
Falk, E.3
Casscells, S.W.4
Litovsky, S.5
Rumberger, J.6
Badimon, J.J.7
Stefanadis, C.8
Moreno, P.9
Pasterkamp, G.10
Fayad, Z.11
Stone, P.H.12
Waxman, S.13
Raggi, P.14
Madjid, M.15
Zarrabi, A.16
Burke, A.17
Yuan, C.18
Fitzgerald, P.J.19
Siscovick, D.S.20
De, K.C.L.21
Aikawa, M.22
Airaksinen, K.E.J.23
Assmann, G.24
Becker, C.R.25
Chesebro, J.H.26
Farb, A.27
Galis, Z.S.28
Jackson, C.29
Jang, I.-K.30
Koenig, W.31
Lodder, R.A.32
March, K.33
Demirovic, J.34
Navab, M.35
Priori, S.G.36
Rekhter, M.D.37
Bahr, R.38
Grundy, S.M.39
Mehran, R.40
Colombo, A.41
Boerwinkle, E.42
Ballantyne, C.43
Insull Jr., W.44
Schwartz, R.S.45
Vogel, R.46
Serruys, P.W.47
Hansson, G.K.48
Faxon, D.P.49
Kaul, S.50
Drexler, H.51
Greenland, P.52
Muller, J.E.53
Virmani, R.54
Ridker, P.M.55
Zipes, D.P.56
Shah, P.K.57
Willerson, J.T.58
more..
-
3
-
-
70450189795
-
Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice
-
Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-2138.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2129-2138
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
5
-
-
77956386145
-
Anti-apolipoprotein A-1 IgG predict major cardiovascular events in patients with rheumatoid arthritis
-
Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA, Finckh A, Lovis C, Mach F, Hochstrasser D, Roux-Lombard P, Gabay C. Anti-apolipoprotein A-1 IgG predict major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2010;62:2640-2650.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2640-2650
-
-
Vuilleumier, N.1
Bas, S.2
Pagano, S.3
Montecucco, F.4
Guerne, P.A.5
Finckh, A.6
Lovis, C.7
Mach, F.8
Hochstrasser, D.9
Roux-Lombard, P.10
Gabay, C.11
-
6
-
-
77950489726
-
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction
-
Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. Eur Heart J 2010;31:815-823.
-
(2010)
Eur Heart J
, vol.31
, pp. 815-823
-
-
Vuilleumier, N.1
Rossier, M.F.2
Pagano, S.3
Python, M.4
Charbonney, E.5
Nkoulou, R.6
James, R.7
Reber, G.8
Mach, F.9
Roux-Lombard, P.10
-
7
-
-
77649140953
-
Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus
-
O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2010;62:845-854.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 845-854
-
-
O'Neill, S.G.1
Giles, I.2
Lambrianides, A.3
Manson, J.4
D'Cruz, D.5
Schrieber, L.6
March, L.M.7
Latchman, D.S.8
Isenberg, D.A.9
Rahman, A.10
-
8
-
-
46449088745
-
Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome
-
Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Clin Sci (Lond) 2008;115:25-33.
-
(2008)
Clin Sci (Lond)
, vol.115
, pp. 25-33
-
-
Vuilleumier, N.1
Charbonney, E.2
Fontao, L.3
Alvarez, M.4
Turck, N.5
Sanchez, J.C.6
Burkhard, P.R.7
Mensi, N.8
Righini, M.9
Reber, G.10
James, R.11
Mach, F.12
Chevrolet, J.C.13
Dayer, J.M.14
Frostegard, J.15
Roux-Lombard, P.16
-
9
-
-
0036791482
-
Oxidized LDL in carotid plaques and plasma associates with plaque instability
-
Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 2002;22:1649-1654.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1649-1654
-
-
Nishi, K.1
Itabe, H.2
Uno, M.3
Kitazato, K.T.4
Horiguchi, H.5
Shinno, K.6
Nagahiro, S.7
-
10
-
-
20444442388
-
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease
-
DOI 10.1111/j.1445-5994.2005.00822.x
-
Zeng B, Prasan A, Fung KC, Solanki V, Bruce D, Freedman SB, Brieger D. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Intern Med J 2005;35:331-335. (Pubitemid 40826856)
-
(2005)
Internal Medicine Journal
, vol.35
, Issue.6
, pp. 331-335
-
-
Zeng, B.1
Prasan, A.2
Fung, K.C.3
Solanki, V.4
Bruce, D.5
Freedman, S.B.6
Brieger, D.7
-
11
-
-
33746826203
-
Novel candidate genes in unstable areas of human atherosclerotic plaques
-
DOI 10.1161/01.ATV.0000229695.68416.76, PII 0004360520060800000023
-
Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, Suckling KE, James CH, Greaves DR, Patel L. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006;26:1837-1844. (Pubitemid 44305338)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.8
, pp. 1837-1844
-
-
Papaspyridonos, M.1
Smith, A.2
Burnand, K.G.3
Taylor, P.4
Padayachee, S.5
Suckling, K.E.6
James, C.H.7
Greaves, D.R.8
Patel, L.9
-
12
-
-
0025734372
-
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis
-
North American Symptomatic Carotid Endarterectomy Trial Collaborators
-
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
-
(1991)
N Engl J Med
, vol.325
, pp. 445-453
-
-
-
13
-
-
0032499446
-
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST)
-
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
-
(1998)
Lancet
, vol.351
, pp. 1379-1387
-
-
-
14
-
-
0032511955
-
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis
-
DOI 10.1056/NEJM199811123392002
-
Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-1425. (Pubitemid 28516064)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.20
, pp. 1415-1425
-
-
Barnett, H.J.M.1
Taylor, D.W.2
Eliasziw, M.3
Fox, A.J.4
Ferguson, G.G.5
Haynes, R.B.6
Rankin, R.N.7
Clagett, G.P.8
Hachinski, V.C.9
Sackett, D.L.10
Thorpe, K.E.11
Meldrum, H.E.12
Spence, J.D.13
-
15
-
-
2342492418
-
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial
-
MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group
-
Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.
-
(2004)
Lancet
, vol.363
, pp. 1491-1502
-
-
Halliday, A.1
Mansfield, A.2
Marro, J.3
Peto, C.4
Peto, R.5
Potter, J.6
Thomas, D.7
-
16
-
-
2942522549
-
Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice
-
DOI 10.1161/01.ATV.0000127025.48140.a3
-
Isoda K, Sawada S, Ishigami N, Matsuki T, Miyazaki K, Kusuhara M, Iwakura Y, Ohsuzu F. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2004;24:1068-1073. (Pubitemid 38737833)
-
(2004)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.24
, Issue.6
, pp. 1068-1073
-
-
Isoda, K.1
Sawada, S.2
Ishigami, N.3
Matsuki, T.4
Miyazaki, K.5
Kusuhara, M.6
Iwakura, Y.7
Ohsuzu, F.8
-
17
-
-
66349137052
-
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis
-
Libby P. Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J Lipid Res 2009;50:S352-S357.
-
(2009)
J Lipid Res
, vol.50
-
-
Libby, P.1
-
18
-
-
33745876256
-
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease
-
DOI 10.1073/pnas.0604260103
-
Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P, Weissleder R. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA 2006;103:10340-10345. (Pubitemid 44051168)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.27
, pp. 10340-10345
-
-
Swirski, F.K.1
Pittet, M.J.2
Kircher, M.F.3
Aikawa, E.4
Jaffer, F.A.5
Libby, P.6
Weissleder, R.7
-
19
-
-
77954176108
-
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke
-
Montecucco F, Lenglet S, Gayet-Ageron A, Bertolotto M, Pelli G, Palombo D, Pane B, Spinella G, Steffens S, Raffaghello L, Pistoia V, Ottonello L, Pende A, Dallegri F, Mach F. Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 2010;41:1394-1404.
-
(2010)
Stroke
, vol.41
, pp. 1394-1404
-
-
Montecucco, F.1
Lenglet, S.2
Gayet-Ageron, A.3
Bertolotto, M.4
Pelli, G.5
Palombo, D.6
Pane, B.7
Spinella, G.8
Steffens, S.9
Raffaghello, L.10
Pistoia, V.11
Ottonello, L.12
Pende, A.13
Dallegri, F.14
Mach, F.15
-
20
-
-
24344433880
-
Matrix metalloproteinases in cerebrovascular diseases
-
DOI 10.1159/000087197
-
Fatar M, Stroick M, Griebe M, Hennerici M. Matrix metalloproteinases in cerebrovascular diseases. Cerebrovasc Dis 2005;20:141-151. (Pubitemid 41254175)
-
(2005)
Cerebrovascular Diseases
, vol.20
, Issue.3
, pp. 141-151
-
-
Fatar, M.1
Stroick, M.2
Griebe, M.3
Hennerici, M.4
-
21
-
-
41149085145
-
Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis
-
DOI 10.1161/CIRCRESAHA.107.160697
-
Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA, Weber C. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008;102:209-217. (Pubitemid 351651125)
-
(2008)
Circulation Research
, vol.102
, Issue.2
, pp. 209-217
-
-
Zernecke, A.1
Bot, I.2
Djalali-Talab, Y.3
Shagdarsuren, E.4
Bidzhekov, K.5
Meiler, S.6
Krohn, R.7
Schober, A.8
Sperandio, M.9
Soehnlein, O.10
Bornemann, J.11
Tacke, F.12
Biessen, E.A.13
Weber, C.14
-
22
-
-
0035677242
-
Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells
-
DOI 10.1002/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2
-
Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 2001;44:2851-2861. (Pubitemid 34016205)
-
(2001)
Arthritis and Rheumatism
, vol.44
, Issue.12
, pp. 2851-2861
-
-
Radford, D.J.1
Luu, N.T.2
Hewins, P.3
Nash, G.B.4
Savage, C.O.S.5
-
24
-
-
51749096897
-
Intravenous immunoglobulin - Indications and mechanisms in cardiovascular diseases
-
Udi N, Yehuda S. Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases. Autoimmun Rev 2008;7:445-452.
-
(2008)
Autoimmun Rev
, vol.7
, pp. 445-452
-
-
Udi, N.1
Yehuda, S.2
-
26
-
-
34247201438
-
Plaque rupture in humans and mice
-
DOI 10.1161/01.ATV.0000261709.34878.20
-
Schwartz SM, Galis Z, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007;27:705-713. (Pubitemid 46606695)
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, Issue.4
, pp. 705-713
-
-
Schwartz, S.M.1
Galis, Z.S.2
Rosenfeld, M.E.3
Falk, E.4
-
27
-
-
73649134029
-
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
-
Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreos KE. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 2010;208:3-9.
-
(2010)
Atherosclerosis
, vol.208
, pp. 3-9
-
-
Tsompanidi, E.M.1
Brinkmeier, M.S.2
Fotiadou, E.H.3
Giakoumi, S.M.4
Kypreos, K.E.5
|